ALLENTOWN, PA, US, March 17, 2022 /EINPresswire.com/ — PursueCare, one of the leading national providers for virtual substance use disorder and mental health treatment, today announced the launch of virtual care services and outpatient clinic services in Pennsylvania and New Jersey. PursueCare also announced the...

Ascend Labs & PursueCare Establish Patient Preference Referral Program February 23, 2022 Responding to increasing numbers of patients calling to request Ascend Laboratories (“Ascend”) brand pharmaceuticals, Ascend has teamed up with PursueCareRX, a national mail-order and retail pharmacy, to refer patients for dispensing of their...

JANUARY 31, 2022PRESS RELEASESSOURCE: ATA WASHINGTON, DC, JANUARY 31, 2022 – Today, 336 organizations sent a letter to Congress urging their leadership in facilitating a pathway to comprehensive permanent telehealth reform that would provide certainty to patients and our nation’s healthcare providers while providing sufficient...

By Nick Mercadante, JD.CEO & Founder, PursueCareNovember 9, 2021 The DEA takes an aggressive stance towards pharmacies that dispense medications used in Medication-Assisted Treatment (MAT) for Substance Use Disorder. This is incredibly short-sighted and does not have positive results for either pharmacies or people living...